| Genmab A/S |
| Datum/Vreme | / |
| Promena / Promena(%) | - / |
| Tražnja | - |
| Ponuda | - |
| Cena na otvaranju | - |
| Prethodno zatvaranje | - |
| Najviša cena | - |
| Najniža | - |
| Obim [DKK] | - |
| Obim [Jedinice] | |
| Dogovorena cena | |
| ISIN | DK0010272202 |
| Simbol | GMAB |
| Berza | OMX Nordic |
| Vrsta | Stock |
Druge berze
| Berza | Poslednja cena | Obim | |
|---|---|---|---|
| Cboe Europe .. | 2.252,00 |  |
19.354 |
| London Inter.. | 2.228,5 |  |
10.834 |
| Turquoise | 2.248,00 | |
9.289 |
| Nasdaq Other.. | 361,0800 | |
179 |
| TradeGate | 303,600 | |
85 |
| gettex | 305,100 | |
5 |
| Vienna Globa.. | 302,30 | |
0 |
| München | 295,70 | |
0 |
| Düsseldorf | 303,30 | |
0 |
| Frankfurt | 300,7000 | |
0 |
| Berlin | 303,20 | |
0 |
| Lang & Schwa.. | 303,30 | |
|
| Stuttgart | 299,900 | |
|
| OMX Nordic | 2.206,00 | |
226.808 |
| Cboe Europe .. | 2.226,00 | 265 | |
| Cboe Europe .. | 2.220,00 | 115 | |
| Mexico | 7.638,15 |  |
11.330 |
Vesti
- Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
20.04.2021 / 12:34 - GlobeNewswire - Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
19.04.2021 / 10:00 - GlobeNewswire - Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
09.04.2021 / 22:00 - GlobeNewswire - Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
01.04.2021 / 12:45 - GlobeNewswire - Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
31.03.2021 / 12:45 - GlobeNewswire
Realno vreme